Hypocholesterolemic Effect Of Spirulina In Patients With Hyperlipidemic Nephrotic Syndrome
Notes for this study:
||Mean and SD. mg/dl Control: before 26.05 ± 10.23, after 107.75 ± 64.27. Spirulina: before 227.98 ± 121.0, after 160.26 ± 121.99.
|Number of Subjects
In a 2-month randomized trial, 23 children with nephrotic syndrome took 1 g/d of spirulina with medication or only medication.
Weight, BMI, and waist-hip ratio weren't different.
The spirulina group saw a statistically significant reduction (compared with baseline) in triglycerides and VLDL-C, while the reduction in the control group was nonsignificant. Fasting glucose, total cholesterol, and LDL were reduced more in the spirulina group, but either the difference compared with baseline wasn't statistically significant, or the reduction in the control group was also statistically significant. HDL was reduced a little more in the control group, but the reduction wasn't significant.